Pharmaceutical company that developed the anxiety medication Valium.
3 AI-extracted insights from 3 sources — podcasts, YouTube channels, and X/Twitter accounts.
Based on 1 scored insight about Roche Holding AG.
The 3 sources with the most insights about Roche Holding AG on Kazuha.
AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.
Part of the European large-caps considered unattractive compared to U.S. growth assets.
Included on a global watchlist of large-cap pharma companies to track the sector, with no specific buy or sell thesis mentioned.
Faces a significant reputational risk as its well-known brand, Valium, is being counterfeited and associated with overdose deaths, potentially leading to stricter regulatory controls.
Part of the European large-caps considered unattractive compared to U.S. growth assets.
Included on a global watchlist of large-cap pharma companies to track the sector, with no specific buy or sell thesis mentioned.
Faces a significant reputational risk as its well-known brand, Valium, is being counterfeited and associated with overdose deaths, potentially leading to stricter regulatory controls.
Other assets that creators frequently mention in the same content as Roche Holding AG.
The most active sources covering Roche Holding AG (ROG.SW) on Kazuha are @realmartinshkreli, Steve Eisman, The Wall Street Journal & Spotify Studios. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.
Kazuha has indexed 3 AI-extracted insights about Roche Holding AG (ROG.SW) from 3 different sources. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.
Creators covering Roche Holding AG (ROG.SW) most frequently also discuss NVS, NVDA, IONQ, LITE, ROKU. See the "Discussed alongside" section above for full asset pages.